On Oct. 20, IAMGOLD Corp. (NYSE:IAG) announced additional drilling results from its 100% owned Boto Gold Project in eastern Senegal, West Africa. The Company is reporting assay results from 36 diamond drill holes totaling over 9,200 metres completed year to date during the 2014 exploration program. IAMGOLD Corp. (NYSE:IAG) in last trading activity advanced 0.86% to close at $2.34. Company weekly performance is -5.26% while its quarterly performance stands at -37.77%. IAMGOLD Corp. (NYSE:IAG) is -58.14% away from its 52 week high.On Oct 20, Gilead Sciences, has broken ground on a new $50 million lab facility in northeast Edmonton, the company says. The 44,000-square-foot lab is the second Gilead lab in Edmonton, where the Foster City, Calif.-based company already employs 300 staff.On last trading day Gilead Sciences Inc. (NASDAQ:GILD) advanced 1.03% to close at $107.18. Its volatility for the week is 2.99% while volatility for the month is 3.58%. GILD's sales growth for past 5 years was 16.00% and its EPS growth for past 5 years was 11.90%. Gilead Sciences Inc. (NASDAQ:GILD) monthly performance is -1.41%.On Oct. 9, The youth and community of Kissimmee, Florida, are getting a new place to play thanks Nathan's Famous Inc. (NASDAQ:NATH) and KaBOOM!. In partnership with the City of Kissimmee and Community Vision, the world famous hot dog company and national non-profit dedicated to giving kids the play they need to thrive have announced plans to build a new playground at the Mark E. Durbin Community Park at Lakeside in the central Florida town.On last trading day Nathan's Famous Inc. (NASDAQ:NATH) decreased -0.09% to close at $68.38. Its volatility for the week is 4.16% while volatility for the month is 3.90%. NATH's sales growth for past 5 years was 11.00% and its EPS growth for past 5 years was 17.70%. Nathan's Famous Inc. (NASDAQ:NATH) monthly performance is 12.30%.CoreLogic, Inc. (NYSE:CLGX) ReportsBristol-Myers Squibb (NYSE:BMY) will release its Q3 2014 results on October 24th. We expect strong performance from its key drugs Eliquis and Yervoy. Additionally, the anti-viral drugs business will see the impact of the approval of the HCV drug Daklinza in Europe and Japan. Overall, we expect reasonable growth for Bristol-Myers Squibb. Additionally, the recent HCV approval and the expected approval of its immuno-oncology drug Nivolumab are something to cheer about and could support the company’s growth over next 5-6 years. Here is what the investors can expect from Bristol-Myers Squibb’s upcoming earnings. Bristol-Myers Squibb Company (NYSE:BMY) in last trading activity advanced 1.27% to close at $52.50. Company weekly performance is 6.66% while its quarterly performance stands at 7.06%. Bristol-Myers Squibb Company (NYSE:BMY) is -6.70% away from its 52 week high.Semiconductor company TriQuint Semiconductor, Inc. (NASDAQ:TQNT) used NI's AWS Microwave Office and Visual System Simulator software tools to design an Edge/GSM power amplifier for use in a mobile handset, accurately characterising the amplifier's circuit performance at system level, and predicting adjacent channel power ratio measurements (ACPR) to minimise the effect of spectral spreading to ensure compliance. On last trading day TriQuint Semiconductor, Inc. (NASDAQ:TQNT) advanced 2.87% to close at $17.55. Its volatility for the week is 4.32% while volatility for the month is 5.20%. TQNT's sales growth for past 5 years was 9.30% and its EPS growth for past 5 years was -19.10%. TriQuint Semiconductor, Inc. (NASDAQ:TQNT) monthly performance is -12.34%.Energy Transfer Equity, L.P. (NYSE:ETE)’s Director Kelcy L. Warren acquired 1,178,567 shares of the stock in a transaction dated Tuesday, October 14th. The shares were purchased at an average cost of $51.30 per share, for a total transaction of $60,460,487.10. On last trading day Energy Transfer Equity, L.P. (NYSE:ETE) decreased -0.91% to close at $57.71. Its volatility for the week is 3.39% while volatility for the month is 5.99%. ETE's sales growth for past 5 years was 39.10% and its EPS growth for past 5 years was -19.20%. Energy Transfer Equity, L.P. (NYSE:ETE) monthly performance is -5.75%.Dillard's Inc. (NYSE:DDS) EVP Drue Matheny sold 10,000 shares of the company’s stock in a transaction that occurred on Tuesday, October 14th. The shares were sold at an average price of $103.45, for a total transaction of $1,034,500.00. Following the transaction, the executive vice president now directly owns 39,030 shares in the company, valued at approximately $4,037,654.Dillard's Inc. (NYSE:DDS) has 10.60% insider ownership while its institutional ownership stands at 92.80%. In last trading activity company's stock closed at $108.05.Jewellery retailers Cartier and Tiffany & Co (NYSE:TIF) have once again made it into a global ranking of the world’s best brands. This year, Cartier and Tiffany & Co. (NYSE:TIF) were the only jewellery companies that made the list, with both having increased positions from 2013. Tiffany’s listing lifted from 75 to 71 and its brand value increased 9 per cent from US$5.4 billion (AU$6.2 b) to US$5.9 billion (AU$6.8 b). This was a slight increase from the previous year when its brand value rose 5 per cent.On Thursday shares of Tiffany & Co. (NYSE:TIF) closed at $94.40. Company's sales growth for last 5 years was 7.20% and EPS growth for next 5 years is recorded as 11.76%.Third Quarter 2014 Financial Results. Total revenues up 3% to $367.5 million fueled by 23% growth in Data and Analytics (D&A) revenues. CoreLogic, Inc. (NYSE:CLGX) has 0.50% insider ownership while its institutional ownership stands at 88.50%. In last trading activity company's stock closed at $30.28.Wunderlich upped their price objective on shares of Invesco Mortgage Capital (NYSE:IVR) from $17.00 to $19.00 in a research note issued on Friday. The firm currently has a “buy” rating on the stock. Wunderlich’s price objective suggests a potential upside of 18.53% from the stock’s previous close. On Thursday shares of Invesco Mortgage Capital Inc. (NYSE:IVR) closed at $16.41. Company's EPS growth for next 5 years is recorded as 5.00%.






